Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berk P. D., Jones E. A., Plotz P. H., Seeff L. B., Wright E. C. Corticosteroid therapy for chronic active hepatitis. Ann Intern Med. 1976 Oct;85(4):523–525. doi: 10.7326/0003-4819-85-4-523. [DOI] [PubMed] [Google Scholar]
- Brunt P. W. Antitrypsin and the liver. Gut. 1974 Jul;15(7):573–580. doi: 10.1136/gut.15.7.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cook G. C., Mulligan R., Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med. 1971 Apr;40(158):159–185. doi: 10.1093/oxfordjournals.qjmed.a067264. [DOI] [PubMed] [Google Scholar]
- Dietrichson O., Christoffersen P. The prognosis of chronic aggressive hepatitis. A clinical and morphological follow-up study. Scand J Gastroenterol. 1977;12(3):289–295. doi: 10.3109/00365527709180930. [DOI] [PubMed] [Google Scholar]
- Eddleston A. L., Williams R. Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet. 1974 Dec 28;2(7896):1543–1545. doi: 10.1016/s0140-6736(74)90287-6. [DOI] [PubMed] [Google Scholar]
- Eleftheriou N., Thomas H. C., Heathcote J., Sherlock S. Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease. Lancet. 1975 Dec 13;2(7946):1171–1173. doi: 10.1016/s0140-6736(75)92657-4. [DOI] [PubMed] [Google Scholar]
- Murray-Lyon I. M., Stern R. B., Williams R. Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet. 1973 Apr 7;1(7806):735–737. doi: 10.1016/s0140-6736(73)92125-9. [DOI] [PubMed] [Google Scholar]
- Sherlock S. Predicting progression of acute type-B hepatitis to chronicity. Lancet. 1976 Aug 14;2(7981):354–356. doi: 10.1016/s0140-6736(76)92607-6. [DOI] [PubMed] [Google Scholar]
- Soloway R. D., Summerskill W. H., Baggenstoss A. H., Geall M. G., Gitnićk G. L., Elveback I. R., Schoenfield L. J. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology. 1972 Nov;63(5):820–833. [PubMed] [Google Scholar]
- Sternlieb I., Scheinberg I. H. Chronic hepatitis as a first manifestation of Wilson's disease. Ann Intern Med. 1972 Jan;76(1):59–64. doi: 10.7326/0003-4819-76-1-59. [DOI] [PubMed] [Google Scholar]
- Summerskill W. H., Korman M. G., Ammon H. V., Baggenstoss A. H. Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut. 1975 Nov;16(11):876–883. doi: 10.1136/gut.16.11.876. [DOI] [PMC free article] [PubMed] [Google Scholar]